{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:22:17Z","timestamp":1762507337624,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.brachy.2018.01.008","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T19:27:51Z","timestamp":1519673271000},"page":"517-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Quality of life up to 10\u00a0years after external beam radiotherapy and\/or brachytherapy for prostate cancer"],"prefix":"10.1016","volume":"17","author":[{"given":"Carla","family":"Freiberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Berneking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas-Alexander","family":"V\u00f6geli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Kirschner-Hermanns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Eble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6450-297X","authenticated-orcid":false,"given":"Michael","family":"Pinkawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2018.01.008_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.brachy.2018.01.008_bib2","first-page":"71","article-title":"Cancer statistics","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2018.01.008_bib3","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/jnci\/djp262","article-title":"Contemporary risk profile of prostate cancer in the United States","volume":"101","author":"Shao","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2018.01.008_bib4","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/j.1464-410X.2011.10632.x","article-title":"Biochemical outcome after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy: 12 years of experience","volume":"109","author":"Prada","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2018.01.008_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13014-015-0349-0","article-title":"Iodine-125 seed brachytherapy for early stage prostate cancer: A single-institution review","volume":"10","author":"Zuber","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2018.01.008_bib6","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brachy.2018.01.008_bib7","doi-asserted-by":"crossref","first-page":"853487","DOI":"10.1155\/2012\/853487","article-title":"Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer","volume":"2012","author":"Hunter","year":"2012","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.brachy.2018.01.008_bib8","first-page":"2206","article-title":"Health related quality of life for men treated for localized prostate cancer with long-term followup","volume":"183","author":"Huang","year":"2010","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.brachy.2018.01.008_bib9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.eururo.2014.08.074","article-title":"Long-term health-related quality of life after primary treatment for localized prostate cancer: Results from the CaPSURE registry","volume":"68","author":"Punnen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2018.01.008_bib10","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1200\/JCO.2009.25.3245","article-title":"Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment","volume":"28","author":"Pardo","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.01.008_bib11","doi-asserted-by":"crossref","first-page":"b4817","DOI":"10.1136\/bmj.b4817","article-title":"Quality of life three years after diagnosis of localised prostate cancer: Population based cohort study","volume":"339","author":"Smith","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.brachy.2018.01.008_bib12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brachy.2018.01.008_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2010.02.010","article-title":"Prostate-specific antigen kinetics following external-beam radiotherapy and temporary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer","volume":"96","author":"Pinkawa","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2018.01.008_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1748-717X-5-27","article-title":"Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study","volume":"5","author":"Pinkawa","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2018.01.008_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2007.05.051","article-title":"Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer","volume":"70","author":"Pinkawa","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.01.008_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.01.008_bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13014-017-0837-5","article-title":"Long-term prognostic significance of rising PSA levels following radiotherapy for localized prostate cancer - focus on overall survival","volume":"12","author":"Freiberger","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2018.01.008_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","article-title":"ASCENDE-RT: A multicenter, randomized trial of dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Morris","year":"2016","journal-title":"Int J Radiat Oncol Phys"},{"key":"10.1016\/j.brachy.2018.01.008_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijrobp.2017.02.027","article-title":"ASCENDE-RT: An analysis of health-related quality of life for a randomized trial comparing low-dose-rate brachytherapy boost with dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.01.008_bib20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","article-title":"ASCENDE-RT: An analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.01.008_bib21","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1464-410X.2011.10460.x","article-title":"Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer","volume":"109","author":"Emara","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2018.01.008_bib22","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/01.ju.0000052720.62999.a9","article-title":"Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors","volume":"169","author":"Martinez","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2018.01.008_bib23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0360-3016(98)00097-2","article-title":"High dose-rate afterloading 192Iridium prostate brachytherapy: Feasibility report","volume":"41","author":"Mate","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.01.008_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2407-9-296","article-title":"Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: Evaluation before a curative treatment","volume":"9","author":"Pinkawa","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.brachy.2018.01.008_bib25","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1200\/JCO.2005.07.116","article-title":"Long-term outcomes among localized prostate cancer survivors: Health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy","volume":"23","author":"Miller","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.01.008_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/01.ju.0000129236.56712.e7","article-title":"Bowel function and bother after treatment for early stage prostate cancer: A longitudinal quality of life analysis from CaPSURE","volume":"172","author":"Litwin","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2018.01.008_bib27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0360-3016(01)02675-X","article-title":"Erectile function after permanent prostate brachytherapy","volume":"52","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.01.008_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.eururo.2008.03.026","article-title":"Erectile dysfunction after external beam radiotherapy for prostate cancer","volume":"55","author":"Pinkawa","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2018.01.008_bib29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ijrobp.2008.11.058","article-title":"Erectile function durability following permanent prostate brachytherapy","volume":"75","author":"Taira","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.01.008_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00130404-200503000-00007","article-title":"Posttreatment complications of early-stage prostate cancer patients: Brachytherapy versus three-dimensional conformal radiation therapy","volume":"11","author":"Tsui","year":"2005","journal-title":"Cancer J"},{"key":"10.1016\/j.brachy.2018.01.008_bib31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/COC.0b013e318172dcb7","article-title":"Biochemical and functional outcomes following brachytherapy with or without supplemental therapies in men < or\u00a0= 50 years of age with clinically organ-confined prostate cancer","volume":"31","author":"Merrick","year":"2008","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.01.008_bib32","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1200\/JCO.2008.18.6486","article-title":"Individualizing quality-of-life outcomes reporting: How localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function","volume":"27","author":"Chen","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.01.008_bib33","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2003.01.199","article-title":"Time course and predictors of symptoms after primary prostate cancer therapy","volume":"21","author":"Talcott","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.01.008_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijrobp.2006.03.055","article-title":"Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: Consequential late damage","volume":"66","author":"Heemsbergen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.01.008_bib35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1538-4721(02)00014-4","article-title":"Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy","volume":"1","author":"Crook","year":"2002","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2018.01.008_bib36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.radonc.2013.05.002","article-title":"GEC\/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update","volume":"107","author":"Hoskin","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2018.01.008_bib37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brachy.2011.09.008","article-title":"American Brachytherapy consensus guidelines for high-dose-rate prostate brachytherapy","volume":"11","author":"Yamada","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2018.01.008_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brachy.2016.06.003","article-title":"The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy for prostate cancer","volume":"16","author":"Bittner","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2018.01.008_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brachy.2011.07.005","article-title":"American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy","volume":"11","author":"Davis","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2018.01.008_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2016.09.006","article-title":"American Brachytherapy Society Task Group Report: Combination of brachytherapy and external beam radiation for high-risk prostate cancer","volume":"16","author":"Spratt","year":"2017","journal-title":"Brachytherapy"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118300102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118300102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:13:07Z","timestamp":1761531187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472118300102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1538472118300102"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2018.01.008","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life up to 10\u00a0years after external beam radiotherapy and\/or brachytherapy for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2018.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}